Internal Medicine, Hematology & Oncology · New York, NY
NPI
1760786388
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
156 William St Fl 7, 7th Fl
New York, NY, 10038
Phone (212) 312-5920
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
807 services
Medicare patients, 2024
245
Average age 76
Drug cost, 2024
$5.8M
911 prescriptions
Company payments, 2025
$5,568
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lan Mo was code 99214 (office e&m - established), 556 times for 149 patients. In total Lan Mo billed 807 services in 13 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 556 | 149 | $82.78 | $46K |
| 99213 Office E&M - Established | Office | 75 | 61 | $56.94 | $4,271 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 18 | $69.71 | $2,022 |
| 99222 Hospital E&M - Initial | Facility | 26 | 26 | $116.11 | $3,019 |
| 99223 Hospital E&M - Initial | Facility | 26 | 26 | $150.93 | $3,924 |
| 99204 Office E&M - New | Office | 24 | 24 | $119.38 | $2,865 |
| 85060 Test - Miscellaneous | Facility | 21 | 21 | $20.89 | $439 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 13 | $104.64 | $1,883 |
By year: 2022 $65K for 633 services; 2023 $53K for 620 services; 2024 $68K for 807 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lan Mo prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 183 prescriptions and refills. In total Lan Mo wrote 911 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 183 | 183 | 35 | $3.3M |
| Ondansetron Odt Ondansetron | 73 | 75 | 35 | $2,228 |
| Eliquis Apixaban | 61 | 61 | 14 | $36K |
| Prednisone Generic | 60 | 63 | 25 | $231 |
| Abiraterone Acetate Generic | 52 | 54 | 14 | $181K |
| Hydrocortisone Generic | 39 | 41 | 18 | $257 |
| Omeprazole Generic | 27 | 31 | 12 | $206 |
| Hydroxyurea Generic | 26 | 26 | Under 11 | $282 |
| Anastrozole Generic | 24 | 24 | Under 11 | $431 |
| Xtandi Enzalutamide | 24 | 24 | Under 11 | $326K |
| Levothyroxine Sodium Generic | 23 | 23 | 11 | $124 |
| Folic Acid Generic | 21 | 21 | Under 11 | $8.08 |
| Gilotrif Afatinib Dimaleate | 17 | 17 | Under 11 | $188K |
| Lenvima Lenvatinib Mesylate | 16 | 16 | Under 11 | $366K |
| Loperamide Loperamide Hcl | 15 | 17 | Under 11 | $206 |
Brand drugs: 403 claims; generic drugs: 508 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lan Mo $5,568 ($5,568 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $4,429.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $4,429 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $149 |
| Daiichi Sankyo Inc. 4568.T | 5 | $125 |
| Exelixis Inc. EXEL | 1 | $125 |
| Janssen Biotech, Inc. JNJ | 4 | $101 |
| Merck Sharp & Dohme LLC MRK | 4 | $86.72 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $76.57 |
| Genmab U.S., Inc. GMAB | 2 | $52.22 |
| Agios Pharmaceuticals, Inc. AGIO | 2 | $51.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.